Doctors against Palantir's NHS software put ‘ideology over patient interest'
Louis Mosley appeared in front of the Science, Innovation and Technology Committee on Tuesday as part of its innovation showcase.
While there, he also challenged claims that Palantir has a 'reputational difficulty' and said it is 'very proud' of the work it does in Israel.
Palantir was co-founded by billionaire tech entrepreneur Peter Thiel, who was an early backer of US President Donald Trump, and has worked with the US government.
It was announced in November 2023 that a group led by Palantir had secured a £330 million contract to provide the NHS Federated Data Platform (FDP).
The shared software system will aim to make it easier for health and care organisations to work together and provide better services to patients, but Palantir's involvement sparked concerns about how patient data will be used.
When asked by MPs about how the company protects patient privacy, and if data would be processed outside of the UK, or be accessible by any foreign government, Mr Mosley said: 'The critical thing to bear in mind about the way our software works and the way it's deployed in the NHS, is that the data controllers – so those organisations that have that legal responsibility, in the NHS those are trusts, typically – they maintain control over their data.
'So each of them gets their own instance of our software, and they control who has access to it, they control what data is integrated into it, and they, in effect, implement and enforce the data protection policies that they deem appropriate.'
He also emphasised Palantir does not 'derive any economic benefit from the data, the data belongs to the customer'.
Mr Mosley claimed that medics who oppose Palantir's involvement in the FDP as choosing 'ideology over patient interest'.
It comes after the British Medical Association (BMA) passed a motion stating the company is an 'unacceptable choice' for the FDP at its annual representative meeting in Liverpool last month.
The union's members voted in favour of the BMA lobbying against the introduction of Palantir software in the health service, and called for the Department of Health and Social Care to create an audit of the progress of the uptake of the systems throughout the NHS.
When asked about this, Mr Mosley said: 'I was very disappointed to see that. I think the accusation that we lack transparency or this is secretive is wrong.
'I think the BMA has, if I may be frank, chosen ideology over patient interest.
'I think our software is going to make patient lives better; so making their treatment quicker, more effective, and ultimately the healthcare system more efficient.
'And I, as a patient, and a user of the NHS, I want it to be as quick and efficient as possible.
'I'm very sad, frankly, that the ideology seems to have taken precedence over those interests.'
The BMA vote comes a little over a year since health workers blockaded the entrance to NHS England's headquarters to call for an end to Palantir's contract.
In April 2024, hundreds of NHS workers protested in central London, holding placards which read 'No Palantir in the NHS' and 'Palantir aids apartheid'.
Mr Mosley also pushed back against claims about Palantir's reputation.
It was put to Mr Mosley that Palantir has a 'reputational difficulty' by Conservative MP Kit Malthouse.
'Everybody's slightly suspicious of what you do,' he said. 'And part of that reputational difficulty has been caused by your software being used in war on Gaza and the targeting of Palestinians with particular characteristics.
'What protections would you put in place for UK programmes to make sure they're not complicit in the commission of war crimes?'
Mr Mosley said he would 'push back' on the question around reputation, adding: 'I think much of that concern and suspicion that you mentioned is the result of misunderstandings about the nature of our software, the nature of our business model and the kind of work we support.
'I would emphasise the fact that we have never worked and will never work in countries that are adversarial to the west, like China or Russia or Iran.
'We do work in Israel. We're proud of the work that we do there. We have provided the Israelis with support since October 7, but also our work there predates those events.
'I can't go into operational details of the way in which our software is used, but I can assure you that I think the systems to which you would think, like Lavender, for example, are not ones that we are involved in.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Rhyl Journal
12 minutes ago
- Rhyl Journal
Graduate overcomes life-changing injuries to fulfil dream of becoming a doctor
Paul Edwards was 17 and studying for his A-levels when he was knocked off his motorbike, suffering multiple fractures. He had to put his studies on hold and delayed his university ambitions for a decade while he recovered. Fast-forward 16 years and, despite living with debilitating pain, Mr Edwards, now aged 32, has graduated in front of his proud parents Charlie and Denise, girlfriend Aesha, close friends and tutors. It was not just his injuries he needed to overcome, as Mr Edwards grew up in Lawrence Weston where only around 15% of students at his secondary achieved five GCSEs. Encouraged by his parents and supportive teachers, he set his sights on studying medicine at the University of Bristol. Prior to his accident he was accepted on to the now obsolete Government-run gifted and talented programme, which sought to help talented students from disadvantaged backgrounds. But in October 2009 a car overran a junction and Mr Edwards collided with the car at 30mph. He suffered catastrophic injuries, including two fractured thighs, multiple fractures to his neck and back, a lacerated liver and head trauma. Mr Edwards spent years in recovery, undergoing multiple surgeries and battling constant pain. In 2014, he had what he calls his 'sink or swim' moment, and with the help of his GP weaned himself off opioid medication. 'I remember my GP saying: 'You can either stay on these drugs and be stuck here, or come off them and find out what life might still offer you',' he said. He enrolled in an access to higher education course and completed the equivalent of three A-levels in nine months. In 2017, Mr Edwards was offered a place to study neuroscience at Bristol, but switched to medicine during the Covid-19 pandemic. 'My sister is a paramedic, and my GP and consultants were so amazingly supportive during my recovery from my accident. I realised I wanted to help. I wanted to give back,' he said. He studied while managing with 'endless and debilitating' pain as a consequence of his injuries. 'I use over-the counter painkillers to treat the pain and I do lots of activity including endurance running and triathlons,' he said. 'I know I'll be in pain anyway, but I would rather be active and in pain, than sedentary and still in pain.' He has recently completed his elective period of study in anaesthetics and will soon begin his foundation doctor training at an NHS hospital on the Isle of Wight. 'I owe the university a lot regarding my success,' Mr Edwards said. 'I have been incredibly well supported, and I really appreciate everything the staff have done for me. 'They really help you achieve the absolute best you can be. I count myself lucky to have met so many wonderful people along the way, who are now absolute friends for life. 'Who knows, maybe the accident was part of a bigger plan – directing me to a path of becoming a doctor> 'I want to let people know that anything is possible if you are determined enough. It's never too late, and Bristol is a great place to be.'
Glasgow Times
13 minutes ago
- Glasgow Times
Graduate overcomes life-changing injuries to fulfil dream of becoming a doctor
Paul Edwards was 17 and studying for his A-levels when he was knocked off his motorbike, suffering multiple fractures. He had to put his studies on hold and delayed his university ambitions for a decade while he recovered. Paul Edwards with his parents Charlie and Denise after graduating from the University of Bristol (Nim Jethwa/University of Bristol/PA) Fast-forward 16 years and, despite living with debilitating pain, Mr Edwards, now aged 32, has graduated in front of his proud parents Charlie and Denise, girlfriend Aesha, close friends and tutors. It was not just his injuries he needed to overcome, as Mr Edwards grew up in Lawrence Weston where only around 15% of students at his secondary achieved five GCSEs. Encouraged by his parents and supportive teachers, he set his sights on studying medicine at the University of Bristol. Prior to his accident he was accepted on to the now obsolete Government-run gifted and talented programme, which sought to help talented students from disadvantaged backgrounds. But in October 2009 a car overran a junction and Mr Edwards collided with the car at 30mph. He suffered catastrophic injuries, including two fractured thighs, multiple fractures to his neck and back, a lacerated liver and head trauma. Paul Edwards (far left) completing the 2025 Bristol 10k with his father, Charlie Edwards, and sister (Paul Edwards/PA) Mr Edwards spent years in recovery, undergoing multiple surgeries and battling constant pain. In 2014, he had what he calls his 'sink or swim' moment, and with the help of his GP weaned himself off opioid medication. 'I remember my GP saying: 'You can either stay on these drugs and be stuck here, or come off them and find out what life might still offer you',' he said. He enrolled in an access to higher education course and completed the equivalent of three A-levels in nine months. In 2017, Mr Edwards was offered a place to study neuroscience at Bristol, but switched to medicine during the Covid-19 pandemic. 'My sister is a paramedic, and my GP and consultants were so amazingly supportive during my recovery from my accident. I realised I wanted to help. I wanted to give back,' he said. He studied while managing with 'endless and debilitating' pain as a consequence of his injuries. 'I use over-the counter painkillers to treat the pain and I do lots of activity including endurance running and triathlons,' he said. 'I know I'll be in pain anyway, but I would rather be active and in pain, than sedentary and still in pain.' Paul Edwards aged 17 in hospital following his accident (Charlie Edwards/PA) He has recently completed his elective period of study in anaesthetics and will soon begin his foundation doctor training at an NHS hospital on the Isle of Wight. 'I owe the university a lot regarding my success,' Mr Edwards said. 'I have been incredibly well supported, and I really appreciate everything the staff have done for me. 'They really help you achieve the absolute best you can be. I count myself lucky to have met so many wonderful people along the way, who are now absolute friends for life. 'Who knows, maybe the accident was part of a bigger plan – directing me to a path of becoming a doctor> 'I want to let people know that anything is possible if you are determined enough. It's never too late, and Bristol is a great place to be.'
South Wales Guardian
an hour ago
- South Wales Guardian
Watchdog bans host of ads for prescription-only weight-loss medications
The Advertising Standards Authority (ASA) said the nine rulings against the ads – one featuring reality TV personality Gemma Collins – made it 'crystal clear' that all injectable forms of weight-loss medication were prescription-only and therefore could not advertised to the public. In December, the ASA warned businesses and individuals who were targeting members of the public with ads for the medicines. It said no-one operating in the industry could say they had not been warned that weight-loss prescription-only medicines 'must not be promoted to the public'. The ads banned this week include an Instagram post by Collins, posted on January 6, which promoted the weight-loss service Yazen. In a video, Collins stated: 'I'm starting this year two sizes down, thanks to Yazen's weight loss app and medication. It's really quick and easy to get started with Yazen, it has absolutely changed my life… I finally found something that actually I lose weight on.' She continued: 'Yes, there's, you know, reports and stuff. And I'm not telling anyone to go on this medication, but it is prescribed on the NHS.' Two complainants challenged whether the ad breached rules because it promoted prescription-only medication to the public. Yazen said the post had been intended to share information about their 'holistic, responsible approach to weight loss', and had not been intended to focus solely on medication. Following notification of the complaint, and in agreement with Collins, the post has been amended to remove any reference to prescription-only medications. Yazen said they would ensure that future posts were compliant with the advertising code. Collins said she took her responsibilities under the advertising code seriously and strove to comply with them. She accepted that her posts had promoted the Yazen weight-loss service and app, and said Yazen would approve any marketing materials she might post in future, and she would follow any guidance that the ASA provided. The ASA also banned an ad for prescription-only weight-loss medication posted by CheqUp, which read: 'No GP or pharmacy visit, just a 2 minute online consultation.' CheqUp told the ASA that they believed the ad had been created in line with what had become widespread industry practice in the weight-loss sector. They assured the ASA that the ad would not appear again. Other providers who have had their ads banned include Juniper UK, Cloud Pharmacy, and Phlo Clinic and SemaPen. The ASA said the rulings established the advertising of named weight-loss drugs such as Wegovy, Mounjaro, Ozempic and Saxenda was banned, as was the use of various claims such as 'obesity treatment jab' and 'weight loss pen'. In April, the ASA said a search in January found around 1,800 unique paid-for weight-loss ads which were identified as potentially advertising a prescription-only medicine. It has published a joint Enforcement Notice with the Medicines and Healthcare products Regulatory Agency and General Pharmaceutical Council, making clear that ads for named weight-loss prescription-only medications are prohibited, including online, on social media and by influencers.
